1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with cholecalciferol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hwang, SJ; Kaang, BK; Kim, JH; Kim, YS; Lee, JA; Park, CH; Son, H; Song, YM | 1 |
Awad, IA; Benavides, CR; Cao, Y; Detter, MR; Gallione, CJ; Girard, R; Griffin, E; Hobson, N; Lightle, R; Marchuk, DA; Moore, T; Neilson, CA; Shen, L; Shenkar, R; Zhang, D | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and cholecalciferol
Article | Year |
---|---|
Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Basic Helix-Loop-Helix Transcription Factors; Calbindin 1; Calbindins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cells, Cultured; Cholecalciferol; Gene Expression Regulation; Hippocampus; Nerve Tissue Proteins; Neurites; Rats; Rats, Sprague-Dawley; RNA Interference; S100 Calcium Binding Protein G; Stem Cells | 2006 |
Novel Murine Models of Cerebral Cavernous Malformations.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Disease; Animals; Apoptosis Regulatory Proteins; Brain; Cholecalciferol; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Gene Deletion; Hemangioma, Cavernous, Central Nervous System; Hemorrhage; Lipopolysaccharides; Mice, Inbred C57BL; Models, Biological; Phenotype; Spin Labels | 2020 |